Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neuroimaging of MAS-XR in ADHD Adolescents at Risk for Bipolar Disorder
NCT02478788Phase 4Completed
- Sponsor
- University of Cincinnati
- Start
- Nov 2015
- Primary completion
- Aug 2022
- Modality
- Small Molecules, Drug Delivery Systems
- Countries
- 1
01
Overview
A Phase 4 trial of adderall xr in attention deficit hyperactivity disorder (ADHD), sponsored by University of Cincinnati. Started Nov 2015; status: completed.
02
Drugs
adderall xr
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NCT02478788.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02478788.